Klebsiella pneumoniae (Kp) is an opportunistic pathogen and the leading cause of healthcare-associated infections, mostly affecting subjects with compromised immune systems or suffering from concurrent bacterial infections. However, the dramatic increase

In 1882, Carl Friedlander described Klebsiella pneumoniae for the first time. He described it as an encapsulated bacillus after isolating the bacterium from the lungs of those who had died from pneumonia. Originally named Friedlander's bacillus, it

Various strains in the genus Klebsiella have evolved to become a major clinical and public health threat worldwide.1 Klebsiella spp. are opportunistic pathogens which are normally found in the flora of healthy individuals’ nose, throat, skin, and intestinal